Open AccessRetrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas
Author(s) -
Vincent A Van Vugt,
David Piccioni,
Bradley Brown,
Tiffany A. Brown,
Marlon Garzo Saria,
Tiffany Juarez,
Santosh Kesari
Publication year - 2014
Publication title -
cns oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 20
eISSN - 2045-0915
pISSN - 2045-0907
DOI - 10.2217/cns.14.29
Subject(s) - temozolomide , medicine , dosing , regimen , retrospective cohort study , oncology , surgery , chemotherapy
We report the safety and feasibility of a 3 days on/11 days off temozolomide regimen for the treatment of recurrent malignant gliomas.